|
|
| 產(chǎn)品基本信息 |
|
| 產(chǎn)品編號：A112552 |
| 產(chǎn)品名稱：ABT 737-d8 |
| 產(chǎn)品CAS：1217686-68-4 |
| 規(guī)格含量：10mg |
| 產(chǎn)品價格：面議 |
| 聯(lián)系我們: |
 |
|
 |
|
|
| 產(chǎn)品詳細(xì)介紹 |
| 標(biāo)準(zhǔn)品編號: |
A112552 |
| 名稱: |
ABT 737-d8 |
| 別名: |
4-[4-[(4’-Chloro[1,1’-biphenyl]-2-yl)methyl]-1-piperazinyl]-N-[[4-[[(1R)-3-(dimethylamino)-1-[(phenylthio)methyl]propyl]amino]-3-nitrophenyl]sulfonyl]benzamide-d8; |
| CAS號: |
1217686-68-4 |
| 備用CAS: |
未標(biāo)記: 852808-04-9 |
| 分子式: |
C??H??D?ClN?O?S? |
| 狀態(tài)： |
Yellow Solid |
| 熔點： |
148-150?C |
| 分子量: |
821.48 |
| 儲存： |
-20°C Freezer |
| 溶解性: |
DMSO |
| 類別: |
Standards; Chiral Molecules; Isotopic Labeled Analogues; Enzyme Activators and Inhibitors; Pharmaceutical/API Drug Impurities/Metabolites; |
| 應(yīng)用: |
A selective inhibitor of BCL-2, in small cell lung cancer. ABT-737 induced dramatic regressions in tumors derived from some SCLC cell lines. |
| 參考: |
|
|
|
|
?您的位置：
